Method of ROI | EMean (kPa), mean ± SD (min-max) | ICC (95% CI) | CV (%) | |
---|---|---|---|---|
Read 1 | Read 2 | |||
Total nodular ROI | ||||
 Intrarater assay (within image) | ||||
  Rater 1 | 25.3 ± 10.0 (12.0–49.6) | 24.7 ± 9.0 (12.1–40.1) | 0.975 (0.983–0.990) | 1.7 |
  Rater 2 | 24.3 ± 11.7 (9.6–58.7) | 24.3 ± 11.9 (9.2–59.9) | 0.999 (0.997–1.000) | 1.4 |
Intrarater assay (different image) | ||||
 Rater 1 | 24.8 ± 9.0 (12.0–40.0) | 24.6 ± 9.4 (9.3–41.7) | 0.959 (0.895–0.984) | 7.6 |
 Rater 2 | 24.3 ± 11.7 (9.6–58.7) | 26.0 ± 13.1 (10.3–60.8) | 0.976 (0.933–0.991) | 7.5 |
 Interrater assay | 25.3 ± 10.0 (12.0–49.6) | 24.3 ± 11.7 (9.6–58.7) | 0.863 (0.653–0.946) | 14.9 |
Focal nodular ROI | ||||
 Intrarater assay (within image) | ||||
  Rater 1 | 34.0 ± 17.2 (14.4–86.3) | 39.6 ± 22.9 (16.3–115.2) | 0.934 (0.842–0.973) | 13.4 |
  Rater 2 | 45.0 ± 36.8 (12.4–179.9) | 36.6 ± 23.4 (10.4–111.8) | 0.866 (0.693–0.945) | 16.9 |
Intrarater assay (different image) | ||||
 Rater 1 | 34.0 ± 17.2 (14.4–86.3) | 33.6 ± 11.9 (11.2–53.7) | 0.894 (0.730–0.958) | 12.3 |
 Rater 2 | 45.0 ± 36.8 (12.4–179.9) | 37.1 ± 19.1 (11.1–93.1) | 0.734 (0.347–0.894) | 19.8 |
 Interrater assay | 34.0 ± 17.2 (14.4–86.3) | 45.0 ± 36.8 (12.4–179.9) | 0.783 (0.443–0.915) | 19.0 |